Annual Report

Overview

The report describes Lepu Biopharma's first annual profit and strong 2025 revenue growth, with consolidated revenue of RMB934.9 million. Its ESG disclosures quantify 2025 Scope 1, Scope 2, and partial Scope 3 emissions, alongside energy and water consumption. The company also reports a zero-fatality workplace safety record while noting two minor work-related injuries.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services